Zantac / Ranitidine (NDMA Cancer) Attorney in Portland, Oregon

Zantac Litigation in Portland

Portland's Multnomah County Circuit Court is one of Oregon's primary venues for complex civil pharmaceutical litigation. Oregon applies Daubert-based reliability standards for expert testimony under OEC 702 and provides a 10-year statute of repose for product liability — giving claimants whose ranitidine use ended within the past decade an additional backstop. Portland-area Zantac claimants should consult national plaintiffs' counsel about Delaware Superior Court filing options as the most active Zantac docket nationally. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Portland Zantac Claimants

Portland-area Zantac claimants should gather pharmacy records from Fred Meyer (Kroger), Rite Aid, Walgreens, and New Seasons Market pharmacies. OHSU Knight Cancer Institute and Providence Cancer Institute records documenting bladder, esophageal, stomach, or colorectal cancer diagnoses are critical. Oregon's 2-year SOL with the discovery rule applies from when the Zantac-NDMA-cancer link was or should have been known.